IRIDEX Appoints Chairman William M. Moore as Interim President & CEO

IRIDEX Corporation

today announced that its board of Directors has named medical device industry veteran William M. Moore., age 63, as interim President and Chief Executive Officer, effective immediately.  Moore replaces Dominik Beck, whose employment with the Company ceased on August 24, 2012.  Moore currently serves, and will continue to serve, as Chairman of the IRIDEX Board of Directors during his tenure as interim Chief Executive Officer.  He has served as a director of the Company since September 2007. The Company also announced that the Board has appointed James Mackaness, age 48, as Chief Operating Officer, effective immediately. Mr. Mackaness will continue to serve in his role as the Company's Chief Financial Officer.  Mackaness joined the Company in January 2008 as Chief Financial Officer. Mackaness stated, "I am very glad to have this opportunity to work more closely with Mr. Moore and the board of directors as the company's Chief Operating Officer.  IRIDEX is a global leader in ophthalmology and I believe well positioned to deliver on its long-standing commitment to profitable operations as we continue to evolve and expand the business." In assuming the